Equities Research Analysts’ updated eps estimates for Thursday, October 5th:

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its buy rating reaffirmed by analysts at Piper Jaffray Companies. The firm currently has a $61.00 target price on the stock.

Assured Guaranty (NYSE:AGO) had its buy rating reaffirmed by analysts at MKM Partners.

Altra Industrial Motion Corp. (NASDAQ:AIMC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $52.00 price target on the stock. According to Zacks, “Over the last six months, Altra Industrial's shares have outperformed the industry. We believe that the company holds solid potential for organic and inorganic growth. For instance, the Stromag acquisition (completed in January) is predicted to be earnings accretive in 2017. Also, the company has been progressing well on its restructuring and cost-saving strategies. For 2017, the company increased its revenue guidance to $850-$865 million from the earlier projection of $840-$855 million. Non-GAAP earnings are anticipated to be $1.95-$2.05 per share, up from $1.83-$1.93 predicted earlier.”

Ambac Financial Group (NASDAQ:AMBC) had its hold rating reissued by analysts at MKM Partners.

Amphenol Corporation (NYSE:APH) had its buy rating reiterated by analysts at Deutsche Bank AG. They currently have a $95.00 target price on the stock.

Astronics Corporation (NASDAQ:ATRO) had its buy rating reissued by analysts at Canaccord Genuity. They currently have a $36.00 target price on the stock.

Alibaba Group Holding Limited (NYSE:BABA) had its strong-buy rating reiterated by analysts at Raymond James Financial, Inc..

BlackBerry Limited (NASDAQ:BBRY) (TSE:BB) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Shares of BlackBerry have outperformed its industry on a year-to-date basis.  The company's decision to focus exclusively on software business seems to be paying off. BlackBerry anticipates profitability (on an adjusted basis) and also expects to generate positive free cash flow in fiscal 2018. In order to strengthen its position in the software business, BlackBerry has recently inked multiple deals as well. The dispute settlement with Qualcomm, earlier this year, is also a huge positive. However, the company's struggles on the top line front raise concerns. With increasing global exposure, BlackBerry faces the risk of adverse foreign exchange fluctuations. Additionally, Brexit and macroeconomic pressures have increased volatility in currency markets and might hurt BlackBerry’s operations. Moreover, the loss of licensing contract with T-Mobile may eventually impact BlackBerry’s sales, given the its expanded network.”

Beazley Plc (OTC:BZLYF) was downgraded by analysts at Numis Securities Ltd from an add rating to a hold rating.

8point3 Energy Partners (NASDAQ:CAFD) had its hold rating reissued by analysts at Oppenheimer Holdings, Inc..

Cinemark Holdings (NYSE:CNK) had its outperform rating reiterated by analysts at Wedbush. Wedbush currently has a $44.00 target price on the stock.

Copart (NASDAQ:CPRT) had its outperform rating reaffirmed by analysts at CJS Securities. They currently have a $42.00 price target on the stock.

Danaher Corporation (NYSE:DHR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $97.00 target price on the stock. According to Zacks, “Year-to-date, Danaher’s shares have outperformed the industry’s average return. The company has an excellent earnings history over the trailing four quarters, beating estimates all through. We are optimistic about the company’s core revenue and earnings growth, on the back of improving order trends and its operating culture, DBS. Going forward, the company expects the biopharma business to be a major growth driver. Its recent acquisitions – Pall and Cepheid – are proving to be strong profit churners, and will boost top-line growth as they become a part of the company’s core revenues. However, on the flip side, slowdown in the company’s academic business in Europe and prolonged sluggishness in the Dental business has restricted growth. Weakness in industrial markets and stiff competition may also hurt the company's financials.”

DISH Network Corporation (NASDAQ:DISH) had its buy rating reaffirmed by analysts at Deutsche Bank AG. Deutsche Bank AG currently has a $99.00 target price on the stock.

DelMar Pharmaceuticals (NASDAQ:DMPI) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $12.00 target price on the stock.

EDF (OTC:ECIFY) was upgraded by analysts at Jefferies Group LLC from a hold rating to a buy rating.

Elbit Systems (NASDAQ:ESLT) was downgraded by analysts at Standpoint Research from an accumulate rating to a hold rating.

FireEye (NASDAQ:FEYE) had its hold rating reissued by analysts at BMO Capital Markets. BMO Capital Markets currently has a $17.00 price target on the stock.

Fortinet (NASDAQ:FTNT) had its buy rating reiterated by analysts at BMO Capital Markets. BMO Capital Markets currently has a $46.00 price target on the stock.

Fortinet (NASDAQ:FTNT) had its buy rating reiterated by analysts at Oppenheimer Holdings, Inc.. The firm currently has a $45.00 price target on the stock.

IAC/InterActiveCorp (NASDAQ:IAC) had its buy rating reaffirmed by analysts at Oppenheimer Holdings, Inc.. The firm currently has a $141.00 target price on the stock, up from their previous target price of $127.00.

IDEX Corporation (NYSE:IEX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $139.00 target price on the stock. According to Zacks, “With a flexible yet disciplined focus on cost and productivity, IDEX expects to successfully tap newer markets to boost its revenue. The company intends to optimize its cost structure, increase competitiveness and reallocate resources to improve profitability. IDEX is currently striving to expand its businesses in the emerging markets by focusing on organic growth. Strategic acquisitions further expand its geographic reach, fill technology gaps and strengthen foothold in the existing markets while expanding its product lines. With diligent execution of operational plans, IDEX outperformed the industry year to date. Management also raised its earlier guidance for 2017 on robust demand patterns and healthy growth dynamics. However, huge recurring R&D expenses increase operating costs and reduce price control over products, which often result in the loss of market share, poor sales and lower operating margins.”

Infosys (NYSE:INFY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Infosys’ Renew New strategy has helped reap multiple benefits, including renewing traditional services, winning deals, introducing services and monetizing from key initiatives. Infosys’ relentless focus on commitment to execution helped it deliver constant currency revenue growth, margin improvement, record cash generation and high revenue per worker in the fiscal first quarter. Its new offerings under its business platforms like Edge, Panaya and Skava are also helping it gain new clients. However, Infosys shares have underperformed the industry average over the past six months. U.S. President-elect Donald Trump’s anti-immigration stance, rising costs and on-site expansion pose as major headwinds. Rapid proliferation of customizable internet-based software has been hampering Infosys’ traditional outsourcing business. Also, the fate of H-1B visas will be a crucial determinant of the company’s future profitability.”

JEAN COUTU GROUP CLASS'A'SUB-VTG (OTC:JCOUF) was upgraded by analysts at Desjardins from a sell rating to a hold rating.

Capital One Financial Corporation started coverage on shares of Lilis Energy (OTC:LLEX). The firm issued an overweight rating and a $7.00 price target on the stock.

MBIA (NYSE:MBI) had its buy rating reissued by analysts at MKM Partners.

MarketAxess Holdings (NASDAQ:MKTX) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “In last one year the stock of MarketAxess Holdings underperformed its industry. The company suffers from escalating expenses. Its operation is also hurt by stringent regulation of U.S and U.K. Intense competition remains another headwind. Nonetheless, its underwriting results have been consistently impressive driven by growth in revenues, improving trading volumes, ongoing investments in areas including Open Trading, launch of products and its strong market position in the U.S. credit. Also, it continues to benefit from its international business, with strength in both emerging markets and Eurobond spaces.”

Mallinckrodt PLC (NYSE:MNK) had its buy rating reissued by analysts at Piper Jaffray Companies. They currently have a $67.00 price target on the stock.

Momenta Pharmaceuticals (NASDAQ:MNTA) had its hold rating reissued by analysts at J P Morgan Chase & Co.

Mylan N.V. (NASDAQ:MYL) had its buy rating reiterated by analysts at UBS AG. UBS AG currently has a $46.00 target price on the stock.

NeoPhotonics Corporation (NYSE:NPTN) was downgraded by analysts at Raymond James Financial, Inc. from an outperform rating to a mkt perform rating.

Oramed Pharmaceuticals (NASDAQ:ORMP) had its buy rating reissued by analysts at HC Wainwright. They currently have a $25.00 price target on the stock.

Park-Ohio Holdings Corp. (NASDAQ:PKOH) had its hold rating reiterated by analysts at FBR & Co.

Dave & Buster’s Entertainment (NASDAQ:PLAY) had its buy rating reissued by analysts at Piper Jaffray Companies. The firm currently has a $69.00 price target on the stock.

Pentair PLC. (NYSE:PNR) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Pentair has guided its full-year 2017 adjusted earnings per share (EPS) guidance of around $3.50 including the negative impact of incremental costs caused by the spin-off of its Electrical business. The company guided third-quarter adjusted EPS guidance range of 91–93 cents and adjusted core sales to grow roughly 4% for the quarter. Going forward, its focus on reorganization activities will fuel growth. The company will also gain from strong performance of the Aquatic & Environmental Systems business. However, lingering weakness in the Engineered Pump businesses, Thermal business and Telecom business, strengthening of the U.S. dollar, as well as price volatility for raw materials remain headwinds. Further, Pentair has underperformed its industry’s performance with respect to share price year to date. “

Pure Storage (NYSE:PSTG) had its positive rating reiterated by analysts at Susquehanna Bancshares Inc. They currently have a $20.00 target price on the stock, up from their previous target price of $18.00.

SeaWorld Entertainment (NYSE:SEAS) had its hold rating reissued by analysts at FBR & Co. The firm currently has a $14.00 target price on the stock.

Sixt SE (ETR:SIX2) had its neutral rating reaffirmed by analysts at DZ Bank AG.

Titan Pharmaceuticals (OTCMKTS:TTNP) had its buy rating reaffirmed by analysts at Roth Capital. Roth Capital currently has a $6.00 price target on the stock.

Veeco Instruments (NASDAQ:VECO) had its buy rating reissued by analysts at Benchmark Co.. Benchmark Co. currently has a $33.00 price target on the stock.

Intrexon Corporation (NYSE:XON) had its outperform rating reaffirmed by analysts at JMP Securities. They currently have a $42.00 target price on the stock.

Zillow Group (NASDAQ:Z) had its buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $55.00 price target on the stock.

Receive News & Stock Ratings for ACADIA Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ACADIA Pharmaceuticals Inc and related stocks with our FREE daily email newsletter.